Semaglutide and tirzepatide are GLP-1 receptor agonists (tirzepatide also targeting GIP), mimicking gut hormones that regulate satiety and blood sugar a well-established pathway with extensive human data
No Impact on IGF-1 or Blood Sugar Levels Unlike full growth hormone therapy, which can increase IGF-1 and affect glucose metabolism, AOD-9604: Does not elevate IGF-1 levels, reducing the risk of unwanted anabolic effects or organ enlargement
Peptides are short chains of amino acids that serve as important messengers within the body
The pre-filled syringe ensures precise dosing and easy administration.
For me, thats not exactly a ringing endorsement
it becomes a little bit more pliable, it loses some of its strength, and it can't handle all the stress from the sports you want to be doing